119 related articles for article (PubMed ID: 18841024)
1. Intermediate interstitial deletion of chromosome 7q detected by first-trimester Down's syndrome screening.
Cheong ML; Tsai MS; Cortes RA; Harrison MR
Fetal Diagn Ther; 2008; 24(4):340-4. PubMed ID: 18841024
[TBL] [Abstract][Full Text] [Related]
2. De novo 7q deletion with a positive maternal serum triple test screening.
Park IY; Jo YS; Shin JC; Sung IK; Kim M
J Obstet Gynaecol Res; 2008 Feb; 34(1):85-7. PubMed ID: 18226135
[TBL] [Abstract][Full Text] [Related]
3. [Prenatal diagnosis of chromosome aberrations after implementation of screening for Down's syndrome].
Kjaergaard S; Hahnemann JM; Skibsted L; Jensen LN; Sperling L; Zingenberg H; Kristiansen A; Brøndum-Nielsen K
Ugeskr Laeger; 2008 Mar; 170(14):1152-6. PubMed ID: 18405480
[TBL] [Abstract][Full Text] [Related]
4. Prenatal diagnosis of de novo t(2;18;14)(q33.1;q12.2;q31.2), dup(5)(q34q34), del(7)(p21.1p21.1), and del(10)(q25.3q25.3) and a review of the prenatally ascertained de novo apparently balanced complex and multiple chromosomal rearrangements.
Chen CP; Chern SR; Lee CC; Lin CC; Li YC; Hsieh LJ; Chen WL; Wang W
Prenat Diagn; 2006 Feb; 26(2):138-46. PubMed ID: 16470734
[TBL] [Abstract][Full Text] [Related]
5. Prenatal diagnosis of a deletion of 18q in a fetus associated with multiple-marker screen positive results.
Chen CP; Chern SR; Liu FF; Jan SW; Lee CC; Chang YC; Yue CT
Prenat Diagn; 1997 Jun; 17(6):571-6. PubMed ID: 9203216
[TBL] [Abstract][Full Text] [Related]
6. Prenatal diagnosis and molecular characterization of an interstitial 1q24.2q25.2 deletion.
Chaabouni M; Martinovic J; Sanlaville D; Attié-Bittach T; Caillat S; Turleau C; Vekemans M; Morichon N
Eur J Med Genet; 2006; 49(6):487-93. PubMed ID: 17142120
[TBL] [Abstract][Full Text] [Related]
7. Interstitial deletion of chromosome 7q and the lack of association with Down syndrome screening markers.
Hafen LB; Rose NC
Fetal Diagn Ther; 2010; 28(1):47. PubMed ID: 20587995
[No Abstract] [Full Text] [Related]
8. If nuchal translucency screening is combined with first-trimester serum screening the need for fetal karyotyping decreases.
Marsk A; Grunewald C; Saltvedt S; Valentin L; Almström H
Acta Obstet Gynecol Scand; 2006; 85(5):534-8. PubMed ID: 16752230
[TBL] [Abstract][Full Text] [Related]
9. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
[TBL] [Abstract][Full Text] [Related]
10. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy.
Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A
Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131
[TBL] [Abstract][Full Text] [Related]
11. Molecular characterisation of a prenatally diagnosed 5q15q21.3 deletion and review of the literature.
Malan V; Martinovic J; Sanlaville D; Caillat S; Waill MC; Ganne ML; Tantau J; Attie-Bitach T; Vekemans M; Morichon-Delvallez N
Prenat Diagn; 2006 Mar; 26(3):231-8. PubMed ID: 16450350
[TBL] [Abstract][Full Text] [Related]
12. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetic characterization of a prenatally detected de novo interstitial deletion of chromosome 2q (2q31.1-q32.1) encompassing HOXD13, ZNF385B and ZNF804A associated with syndactyly and increased first-trimester nuchal translucency.
Chen CP; Lin CJ; Chen YN; Chern SR; Chen SW; Lai ST; Wu PS; Chen LF; Wang W
Taiwan J Obstet Gynecol; 2017 Jun; 56(3):398-401. PubMed ID: 28600059
[TBL] [Abstract][Full Text] [Related]
14. Prenatal diagnosis of the distal 11q deletion and review of the literature.
Chen CP; Chern SR; Chang TY; Tzen CY; Lee CC; Chen WL; Chen LF; Wang W
Prenat Diagn; 2004 Feb; 24(2):130-6. PubMed ID: 14974122
[TBL] [Abstract][Full Text] [Related]
15. Chromosome 1p32-p31 deletion syndrome: prenatal diagnosis by array comparative genomic hybridization using uncultured amniocytes and association with NFIA haploinsufficiency, ventriculomegaly, corpus callosum hypogenesis, abnormal external genitalia, and intrauterine growth restriction.
Chen CP; Su YN; Chen YY; Chern SR; Liu YP; Wu PC; Lee CC; Chen YT; Wang W
Taiwan J Obstet Gynecol; 2011 Sep; 50(3):345-52. PubMed ID: 22030051
[TBL] [Abstract][Full Text] [Related]
16. Inhibin A is a maternal serum marker for Down's syndrome early in the first trimester.
Christiansen M; Nørgaard-Pedersen B
Clin Genet; 2005 Jul; 68(1):35-9. PubMed ID: 15952984
[TBL] [Abstract][Full Text] [Related]
17. Abnormal first trimester screen in partial deletion of chromosome 6p21: a case-report.
Hulsbergen MH; Van Calenbergh SG; Fryns JP
Genet Couns; 2007; 18(2):243-5. PubMed ID: 17710877
[TBL] [Abstract][Full Text] [Related]
18. Discrepancy between the fetus and extra-embryonic tissues in prenatally detected mosaic distal 5p deletion.
Chen CP; Lee CC; Town DD; Lee MS; Wang W
Genet Couns; 2004; 15(4):473-6. PubMed ID: 15658625
[TBL] [Abstract][Full Text] [Related]
19. [Screening by maternal serum markers for Down's syndrome].
Liu JT; Hao N; Sun NH; Wang FY; Xu YH; Gai MY; Bian XM; Yang JQ
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Apr; 25(2):156-9. PubMed ID: 12905710
[TBL] [Abstract][Full Text] [Related]
20. A VARIANT CASE OF 6p24 DELETION SYNDROME (OMIM #612582).
Ergin RN; Cigerciogullari E; Alanay Y; Yayla M
Genet Couns; 2015; 26(2):237-41. PubMed ID: 26349195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
